New England Biolabs Migrates to SAP S/4HANA for Enzyme Production

Case studies

WMS

New England Biolabs Migrates to SAP S/4HANA for Enzyme Production

Case study of NEB replacing manual systems with SAP S/4HANA to automate production planning, create bills of materials, and improve batch traceability for enzyme manufacturing.

Published

June 4, 2026

Read time

3 min read

Source

SAP

New England Biolabs migrated from SAP Business Suite on HANA to SAP S/4HANA to manage growth in recombinant enzyme production. The implementation created full bills of materials for 283 restriction enzymes, automated record keeping, and established material traceability to meet regulatory requirements. SAP Fiori provides simplified monitoring across functions while tighter costing processes improve margin visibility for high-value components.

Key takeaways

Full bills of materials created for every enzyme product documenting components and processes

Material and batch traceability implemented for regulatory compliance and internal visibility

SAP Fiori launchpad deployed for cross-functional monitoring and insight delivery

Automated record keeping increased repeatability of production outcomes

Costing processes tightened for expensive components to improve margin analysis

Market overview

SCR methodology note

Vendor landscape

Leaders

Implementation considerations

Important consideration

Original Source

Vendors mentioned in this report

No items found.